Medium dose rate brachytherapy for patients with cervical carcinoma; Early result of a prospective study

Tehran University Medical Journal

Volumn 66, Issue 12, 2009, Pages 888-893

  Amouzegar Hashemi, F ^a   Zahedi, F ^a   Farhan, F ^a   Kalaghchi, B ^a   Mehrdad, N ^b   Haddad, P ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Brachytherapy; Cervical carcinoma; Medium dose rate (MDR); Radiotherapy

Indexed keywords

ADJUVANT RADIOTHERAPY; ARTICLE; BLADDER DISEASE; BRACHYTHERAPY; CANCER STAGING; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; LOW ENERGY RADIATION; MAJOR CLINICAL STUDY; MEDIUM ENERGY RADIATION; OVERALL SURVIVAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION DOSE REDUCTION; RECTUM DISEASE; TIME TO TREATMENT; TUMOR RECURRENCE; UTERINE CERVIX CARCINOMA;

EID: 85008399752     PISSN: 16831764     EISSN: 17357322     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. th ed. Philadelphia: Lippincott Williams & Wilkins; 2005.
2. th ed. Philadelphia: Lippincott Williams & Wilkins; 2004.
3. Fyles A, Keane TJ, Barton M, Simm J. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol 1992; 25: 273-9.
4. Perez CA, Devineni VR, Marcial-Vega V. Carcinoma of the nasopharynx: factors affecting prognosis. Int J Radiat Oncol Biol Phys 1992; 23: 271-80.
5. Wilkinson JM, Hendry JH, Hunter RD. Dose-rate considerations in the introduction of low-dose-rate afterloading intracavitary techniques for radiotherapy. Br J Radiol 1980; 53: 890-3.
6. Stout R, Hunter RD. Clinical trials of changing dose-rate in. intracavitary Low Dose Rate therapy. In: Mould RF, editor. Brachytherapy 2, Nucletron. Netherlands: International BV; 1989. p. 219-22.
7. Patel FD, Negi PS, Sharma SC, Kapoor R, Singh DP, Ghoshal S. Dose rate correction in medium dose rate brachytherapy for carcinoma cervix. Radiother Oncol 1998; 49: 317-23.
8. Nag S, Chao C, Erickson B, Fowler J, Gupta N, Martinez A, et al. Int J Radiat Oncol Biol Phys 2002; 52: 33-48.
9. Report #38. Dose and volume specification for reporting intracavitary therapy in oncology. Bethesda, MD: International Commission On Radiation Units and Measurements, 1985.
10. Tanaka E, Oh RJ, Yamada Y, Shiomi H, Nakamura S, Shimamoto S, et al. Prospective study of HDR (192Ir) versus MDR (137Cs) intracavitary brachytherapy for carcinoma of the uterine cervix. Brachytherapy 2003; 2: 85-90.
11. Stitt JA, Fowler JF, Thomadsen BR, Buchler DA, Paliwal BP, Kinsella TJ. High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: I. Clinical and radiobiological considerations. Int J Radiat Oncol Biol Phys 1992; 24: 335-48.
12. Newman G. Increased morbidity following the introduction of remote afterloading, with increased dose rate, for cancer of the cervix. Radiother Oncol 1996; 39: 97-103.
13. Rodrigus P, De Winter K, Venselaar JL, Leers WH. Evaluation of late morbidity in patients with carcinoma of the uterine cervix following a dose rate change. Radiother Oncol 1997; 42: 137-41.
14. Patel FD, Negi PS, Sharma SC, Kapoor R, Singh DP, Ghoshal S. Dose rate correction in medium dose rate brachytherapy for carcinoma cervix. Radiother Oncol 1998; 49: 317-23.
15. Ferrigno R, Campos de Oliveira Faria SL, Weltman E, Salvajoli JV, Segreto RA, Pastore A, et al. Radiotherapy alone in the treatment of uterine cervix cancer with telecobalt and low-dose-rate brachytherapy: retrospective analysis of results and variables. Int J Radiat Oncol Biol Phys 2003; 55: 695-706.
16. Perez CA, Camel HM, Kuske RR, Kao MS, Galakatos A, Hederman MA, et al. Radiation therapy alone in the treatment of carcinoma of the uterine cervix: a 20-year experience. Gynecol Oncol 1986; 23: 127-40.
17. Kim RY, Trotti A, Wu CJ, Soong SJ, Salter MM. Radiation alone in the treatment of cancer of the uterine cervix: analysis of pelvic failure and dose response relationship. Int J Radiat Oncol Biol Phys 1989; 17: 973-8.
18. Montana GS, Martz KL, Hanks GE. Patterns and sites of failure in cervix cancer treated in the U.S.A. in 1978. Int J Radiat Oncol Biol Phys 1991; 20: 87-93.
19. Lanciano R, Thomas G, Eifel PJ. 20 Years of Progress in Radiation Oncology: Prostate Cancer. Semin Radiat Oncol 1997; 7: 121-6.
20. Coia L, Won M, Lanciano R, Marcial VA, Martz K, Hanks G. The Patterns of Care Outcome Study for cancer of the uterine cervix. Results of the Second National Practice Survey. Cancer 1990; 66: 2451-6.
21. Eifel PJ, Logsdon MD. FIGO stage IIIB squamous cell carcinoma of the uterine cervix: Natural history, treatment results, and prognostic factors. Int J Radiat Oncol Biol Phys 1996; Suppl 36: 217.
22. Hanks GE, Herring DF, Kramer S. Patterns of care outcome studies. Results of the national practice in cancer of the cervix. Cancer 1983; 51: 959-67.
23. Marcial VA, Amato DA, Marks RD, Rotman M, Canoy N, Figueroa-Vallés NF, et al. Split-course versus continuous pelvis irradiation in carcinoma of the uterine cervix: a prospective randomized clinical trial of the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1983; 9: 431-6.
24. Fyles AW, Pintilie M, Kirkbride P, Levin W, Manchul LA, Rawlings GA. Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis. Radiother Oncol 1995; 35: 107-17.
25. Barillot I, Horiot JC, Pigneux J, Schraub S, Pourquier H, Daly N, et al. Carcinoma of the intact uterine cervix treated with radiotherapy alone: a French cooperative study: update and multivariate analysis of prognostics factors. Int J Radiat Oncol Biol Phys 1997; 38: 969-78.
26. Gasinska A, Fowler JF, Lind BK, Urbanski K. Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone. Acta Oncol 2004; 43: 657-66.